BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18719002)

  • 1. Gastrin increases mcl-1 expression in type I gastric carcinoid tumors and a gastric epithelial cell line that expresses the CCK-2 receptor.
    Pritchard DM; Berry D; Przemeck SM; Campbell F; Edwards SW; Varro A
    Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G798-805. PubMed ID: 18719002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling.
    Varro A; Kenny S; Hemers E; McCaig C; Przemeck S; Wang TC; Bodger K; Pritchard DM
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1133-40. PubMed ID: 17218472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori can induce heparin-binding epidermal growth factor expression via gastrin and its receptor.
    Dickson JH; Grabowska A; El-Zaatari M; Atherton J; Watson SA
    Cancer Res; 2006 Aug; 66(15):7524-31. PubMed ID: 16885350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of
    Sundaresan S; Kang AJ; Hayes MM; Choi EK; Merchant JL
    Gut; 2017 Jun; 66(6):1012-1021. PubMed ID: 26860771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric carcinoid expresses the gastrin autocrine pathway.
    Smith AM; Watson SA; Caplin M; Clarke P; Griffin N; Varro A; Hardcastle JD
    Br J Surg; 1998 Sep; 85(9):1285-9. PubMed ID: 9752879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and characterization of gastrin receptor from ECL carcinoid tumor of Mastomys natalensis.
    Nakata H; Matsui T; Ito M; Taniguchi T; Naribayashi Y; Arima N; Nakamura A; Kinoshita Y; Chihara K; Hosoda S
    Biochem Biophys Res Commun; 1992 Sep; 187(2):1151-7. PubMed ID: 1530611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered influence of CCK-B/gastrin receptors on HDC expression in ECL cells after neoplastic transformation.
    Kölby L; Wängberg B; Ahlman H; Modlin IM; Theodorsson E; Nilsson O
    Regul Pept; 1999 Dec; 85(2-3):115-23. PubMed ID: 10651065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid.
    Annibale B; Azzoni C; Corleto VD; di Giulio E; Caruana P; D'Ambra G; Bordi C; Delle Fave G
    Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1449-56. PubMed ID: 11742193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrin-mediated alterations in gastric epithelial apoptosis and proliferation in a mastomys rodent model of gastric neoplasia.
    Kidd M; Tang LH; Modlin IM; Zhang T; Chin K; Holt PR; Moss SF
    Digestion; 2000; 62(2-3):143-51. PubMed ID: 11025361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histidine decarboxylase expression and histamine metabolism in gastric oxyntic mucosa during hypergastrinemia and carcinoid tumor formation.
    Kölby L; Wängberg B; Ahlman H; Modlin IM; Granérus G; Theodorsson E; Nilsson O
    Endocrinology; 1996 Oct; 137(10):4435-42. PubMed ID: 8828505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of gastrin on the expression of cyclooxygenase-2, hepatocyte growth factor and apoptosis-related proteins in gastric epithelial cells.
    Konturek PC; Kania J; Kukharsky V; Ocker S; Hahn EG; Konturek SJ
    J Physiol Pharmacol; 2003 Mar; 54(1):17-32. PubMed ID: 12674216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of gastrin/CCK receptors on gastric carcinoid tumor membrane of Mastomys natalensis.
    Inomoto Y; Kinoshita Y; Nakamura A; Arima N; Yamashita Y; Nakata H; Yamamura Y; Hosoda S; Chiba T
    Regul Pept; 1993 Feb; 43(3):149-58. PubMed ID: 8441820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrin-induced apoptosis contributes to carcinogenesis in the stomach.
    Cui G; Takaishi S; Ai W; Betz KS; Florholmen J; Koh TJ; Houghton J; Pritchard DM; Wang TC
    Lab Invest; 2006 Oct; 86(10):1037-51. PubMed ID: 16894354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of the fundic enterochromaffin-like (ECL) cell and gastric carcinoid tumours.
    Modlin IM; Lawton GP; Miu K; Kidd M; Luque EA; Sandor A; Tang LH
    Ann R Coll Surg Engl; 1996 Mar; 78(2):133-8. PubMed ID: 8678447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of RegIalpha are associated with enterochromaffin-like cell tumor development in patients with hypergastrinemia.
    Higham AD; Bishop LA; Dimaline R; Blackmore CG; Dobbins AC; Varro A; Thompson DG; Dockray GJ
    Gastroenterology; 1999 Jun; 116(6):1310-8. PubMed ID: 10348814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrin regulates the TFF2 promoter through gastrin-responsive cis-acting elements and multiple signaling pathways.
    Tu S; Chi AL; Lim S; Cui G; Dubeykovskaya Z; Ai W; Fleming JV; Takaishi S; Wang TC
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1726-37. PubMed ID: 17332476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin.
    Iwase K; Evers BM; Hellmich MR; Guo YS; Higashide S; Kim HJ; Townsend CM
    Gastroenterology; 1997 Sep; 113(3):782-90. PubMed ID: 9287969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori, gastrin and cyclooxygenases in gastric cancer.
    Konturek PC; Hartwich A; Zuchowicz M; Labza H; Pierzchalski P; Karczewska E; Bielanski W; Hahn EG; Konturek SJ
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):737-49. PubMed ID: 11192946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
    Lloyd KA; Parsons BN; Burkitt MD; Moore AR; Papoutsopoulou S; Boyce M; Duckworth CA; Exarchou K; Howes N; Rainbow L; Fang Y; Oxvig C; Dodd S; Varro A; Hall N; Pritchard DM
    Cell Mol Gastroenterol Hepatol; 2020; 10(1):113-132. PubMed ID: 32004755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1.
    Lloyd KA; Moore AR; Parsons BN; O'Hara A; Boyce M; Dockray GJ; Varro A; Pritchard DM
    Oncotarget; 2016 Jul; 7(29):45462-45478. PubMed ID: 27323780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.